OKYO Pharma Ltd (NASDAQ:OKYO), focused on developing urcosimod for neuropathic corneal pain, announced that Panetta Partners, in which Executive Chairman Gabriele Cerrone has a beneficial interest, purchased 27,051 shares on NASDAQ, increasing his total holding to 10,491,746 shares.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com